Select Medical reports Q4 growth, 2026 outlook; Ortenzio take-private bid under review

SELECT MEDICAL HOLDINGS CORP

2025-FY EPS reported $1.16 revenue$5,452,830,000

Q4 revenue $1,396.6M (+6.4%), net income $37.7M, diluted EPS $0.16 vs loss $0.19 YoY.
FY2025 revenue $5,452.8M (+5.1%), net income $214.5M (+65%), adjusted EPS $1.16 (+23.4%).
Rehab hospital segment revenue +15.2%, Adj EBITDA +11.1%. Outpatient rehab margin fell to 3.4% from 8.3%.
2026 outlook: revenue $5.6-5.8B, Adj EBITDA $520-540M, diluted EPS $1.22-1.32.
Board declares $0.0625 dividend; $1B stock repurchase authorized through Dec 2027; Ortenzio take-private proposal under review.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.